Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|April 9, 2021
Perovskite Quantum Dots as Multifunctional Interlayers in Perovskite Solar Cells with Dopant-Free Organic Hole Transporting LayersFangwen Cheng, Ruiqin He, Siqing Nie, et al.
BMC Surgery|October 22, 2025
A higher prognostic nutritional index is inversely associated with the need for renal replacement therapy in elderly critically Ill surgical patientsQi Liu, Simin Li, Hailin He, et al.
Frontiers in Nutrition|December 1, 2025
Prognostic nutritional index as a predictor of in-hospital mortality in neonates and infants undergoing cardiac surgeryXiaolin Gu, Jie Li, Xiaoqin Huang, et al.
Frontiers in Oncology|March 30, 2026
Dermatofibrosarcoma protuberans misdiagnosed as lipoma: a case report and literature reviewXinghao Yang, Feiyu Yin, Haiyang Jiang, et al.
Chinese Medical Journal|April 1, 2024
Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trialXiuchun Chen, Zhenduo Lu, Chengzheng Wang, et al.
BMC Cancer|February 6, 2025
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancerDechuang Jiao, Xiuchun Chen, Xianfu Sun, et al.
Translational Andrology and Urology|September 16, 2024
Construction and validation of a prediction model for inguinal lymph node metastasis of penile malignancyKun Zhang, Longguo Dai, Huijian Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 22, 2016
The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?Yadong Sun, Xiaofeng Liu, Shude Cui, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
(Neo)adjuvant therapy patterns and outcomes in patients with HR+/HER2+ early breast cancer: a real-world study using the national cancer information database in ChinaJiujun Zhu, Dechuang Jiao, Chengzheng Wang, et al.
Nature Communications|October 20, 2023
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trialChengzheng Wang, Zhenzhen Liu, Xiuchun Chen, et al.
Pageof 4